HRT Financial’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-27,844
| Closed | -$343K | – | 3611 |
|
|
2024
Q4 | $343K | Sell |
27,844
-149,790
| -84% | -$1.72M | ﹤0.01% | 1642 |
|
|
2024
Q3 | $2.02M | Buy |
177,634
+50,933
| +40% | +$511K | 0.01% | 877 |
|
|
2024
Q2 | $904K | Buy |
+126,701
| New | +$969K | 0.01% | 1060 |
|
|
2024
Q1 | – | Sell |
-442,423
| Closed | -$2.88M | – | 3258 |
|
|
2023
Q4 | $2.88M | Buy |
442,423
+404,260
| +1,059% | +$2.61M | 0.02% | 503 |
|
|
2023
Q3 | $360K | Buy |
+38,163
| New | +$459K | ﹤0.01% | 1577 |
|
|
2023
Q2 | – | Sell |
-79,942
| Closed | -$1.5M | – | 3455 |
|
|
2023
Q1 | $1.5M | Buy |
+79,942
| New | +$1.31M | 0.02% | 740 |
|
|
2022
Q3 | – | Sell |
-52,322
| Closed | -$798K | – | 3651 |
|
|
2022
Q2 | $798K | Buy |
52,322
+39,139
| +297% | +$579K | 0.01% | 1090 |
|
|
2022
Q1 | $268K | Sell |
13,183
-8,733
| -40% | -$178K | ﹤0.01% | 2312 |
|
|
2021
Q4 | $639K | Buy |
+21,916
| New | +$627K | ﹤0.01% | 1574 |
|
|
2021
Q1 | – | Sell |
-33,608
| Closed | -$387K | – | 3252 |
|
|
2020
Q4 | $387K | Buy |
+33,608
| New | +$307K | 0.01% | 1154 |
|
|
2019
Q4 | – | Sell |
-12,878
| Closed | -$68K | – | 1750 |
|
|
2019
Q3 | $68K | Buy |
+12,878
| New | +$79.9K | ﹤0.01% | 1282 |
|
Other funds holding CDMO
HRT Financial's CDMO Position: Q1 2025 in Review
HRT Financial sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 27,844 shares — an estimated $343K sold.
HRT Financial first reported a position in CDMO in Q3 2019 and held it in 11 quarters. The position peaked at $2.88M in Q4 2023. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- HRT Financial reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- HRT Financial sold 27,844 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $343K.
- HRT Financial first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2019 and held it in 11 quarters.
- HRT Financial's Avid Bioservices, Inc. Common Stock position peaked at $2.88M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on HRT Financial's 13F filing for Q1 2025, filed 15 May 2025.